NDC 67544-672 Carbidopa And Levodopa
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 67544 - Aphena Pharma Solutions - Tennessee, Llc
- 67544-672 - Carbidopa And Levodopa
Product Characteristics
Product Packages
NDC Code 67544-672-51
Package Description: 6000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
NDC Code 67544-672-60
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
NDC Code 67544-672-80
Package Description: 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Details
What is NDC 67544-672?
What are the uses for Carbidopa And Levodopa?
Which are Carbidopa And Levodopa UNII Codes?
The UNII codes for the active ingredients in this product are:
- CARBIDOPA (UNII: MNX7R8C5VO)
- CARBIDOPA ANHYDROUS (UNII: KR87B45RGH) (Active Moiety)
- LEVODOPA (UNII: 46627O600J)
- LEVODOPA (UNII: 46627O600J) (Active Moiety)
Which are Carbidopa And Levodopa Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for Carbidopa And Levodopa?
- RxCUI: 308989 - carbidopa 50 MG / levodopa 200 MG Extended Release Oral Tablet
- RxCUI: 308989 - carbidopa (as carbidopa monohydrate) 50 MG / levodopa 200 MG Extended Release Oral Tablet
- RxCUI: 308989 - Carbidopa 50 MG / L-DOPA 200 MG Extended Release Oral Tablet
* Please review the disclaimer below.
Patient Education
Levodopa and Carbidopa
The combination of levodopa and carbidopa is used to treat the symptoms of Parkinson's disease and Parkinson's-like symptoms that may develop after encephalitis (swelling of the brain) or injury to the nervous system caused by carbon monoxide poisoning or manganese poisoning. Parkinson's symptoms, including tremors (shaking), stiffness, and slowness of movement, are caused by a lack of dopamine, a natural substance usually found in the brain. Levodopa is in a class of medications called central nervous system agents. It works by being converted to dopamine in the brain. Carbidopa is in a class of medications called decarboxylase inhibitors. It works by preventing levodopa from being broken down before it reaches the brain. This allows for a lower dose of levodopa, which causes less nausea and vomiting.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".